Infectious diseases and antimicrobial therapy
Clinical research includes bacteraemia, infective endocarditis, septic shock, and severe Gram-negative bacterial infections, with attention to Enterococcus faecalis, Pseudomonas aeruginosa, Enterobacteriaceae, and Staphylococcus aureus.
- Uncomplicated bacteremia and enterococcal infections
- Antibiotic therapy for resistant bacterial infections
- Osteosynthesis material infections after long bone fracture
The sponsor also funds work on targeted antimicrobial treatment and management strategies for implant-associated infections.
Neurology and neurovascular disorders
Research activity covers acute ischemic stroke, primary progressive multiple sclerosis, and Huntington´s disease, alongside studies in schizophrenia spectrum disorders.
- Stroke and reocclusion prevention
- Multiple sclerosis symptom management
- Neurodegenerative disease care in Huntington´s disease
Additional interest extends to cognitive impairment in early psychosis and other central nervous system conditions.
Hematology and cellular therapies
The portfolio includes multiple myeloma, high-risk myelodysplastic syndrome, acute myeloid leukemia, and primary immune thrombocytopenia.
- Hematologic malignancies and relapsed disease
- Immune thrombocytopenia
- Cell-based immunotherapy in multiple myeloma
Research also spans allogeneic transplant settings and conditioning regimens used in advanced blood cancers.
Psychiatry and mental health
Studies address refractory major depression disorder in older adults and schizophrenia, with an emphasis on treatment-resistant presentations and associated cognitive symptoms.
- Depressive disorders in late life
- Psychotic disorders and cognitive impairment
- Antidepressant and antipsychotic treatment strategies
The clinical portfolio also includes research in early psychosis and symptom-focused psychiatric care.
